AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30397963 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 30134772 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) - SC PMTCT plus the 'Protect Your Family' intervention; 6 CHCs; n = 342
Number of subjects: 699
Study 30134772 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC) - Standard Care condition plus time-equivalent attention-control on disease prevention; 6 CHCs; n = 357
Number of subjects: 699
Study 27058233 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended adjuvant letrozole
Number of subjects: 0
Study 24638119 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) intervention to encourage CRC screening (n=10,000)
Number of subjects: 13279
Study 24638119 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=3279)
Number of subjects: 13279
Study 24638119 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR intervention
Number of subjects: 13279
Study 21757401 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole treatment
Number of subjects: 25
Study 21757401 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 25
Study 19637794 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of meropenem (1.0 g/day over 24 hours)
Number of subjects: 100
Study 19637794 — intervention group
Group type: COMPARATOR
Intervention: Intermittent infusion of meropenem (0.5 g infused morning and evening)
Number of subjects: 100
Study 17882870 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh allogenic joints (Group A, n=7)
Number of subjects: 13
Study 17882870 — intervention group
Group type: COMPARATOR
Intervention: Frozen allogenic joints (Group B, n=6)
Number of subjects: 13
Study 17882870 — intervention group
Group type: COMPARATOR
Intervention: Immunological examination (Group A vs Group B)
Number of subjects: 13
Study 15724756 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.0% hydrogen peroxide (Crest Whitestrips)
Number of subjects: 60
Study 15724756 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5% hydrogen peroxide (Crest Professional Whitestrips)
Number of subjects: 60
Study 15724756 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% hydrogen peroxide (Day White Excel 3)
Number of subjects: 60
Study 15724756 — intervention group
Group type: EXPERIMENTAL
Intervention: 9.5% hydrogen peroxide (Day White Excel 3)
Number of subjects: 60
Study 15724756 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (Opalescence)
Number of subjects: 60
Study 15724756 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 60
Study 12466771 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulative treatment of the structures of the shoulder girdle in addition to standard treatment by the general practitioner
Number of subjects: 250
Study 12466771 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment by the general practitioner
Number of subjects: 250
Study 10451015 — intervention group
Group type: EXPERIMENTAL
Intervention: Truth group
Number of subjects: 0
Study 10451015 — intervention group
Group type: EXPERIMENTAL
Intervention: Malinger group
Number of subjects: 0
Study 10451015 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 10159676 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based intervention using touchscreen computer assessment, goal setting, and problem-solving assistance
Number of subjects: 95
Study 10159676 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up components including phone calls and videotape or interactive video instruction
Number of subjects: 95
Study 2140281 — intervention group
Group type: EXPERIMENTAL
Intervention: 5FU monochemotherapy
Number of subjects: 0
Study 2140281 — intervention group
Group type: COMPARATOR
Intervention: Polychemotherapy protocols (FAM and SMF)
Number of subjects: 0
Study 356523 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole
Number of subjects: 30
Study 356523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31937528 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered diabetes self-management program integrating CBT principles
Number of subjects: 195
Study 31937528 — intervention group
Group type: COMPARATOR
Intervention: Peer-delivered general health advice program
Number of subjects: 195
Study 31303190 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week intervention promoting healthier beverages (water, unsweetened low- or non-fat milk)
Number of subjects: 154
Study 31303190 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed-intervention)
Number of subjects: 154
Study 31303190 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week intervention promoting healthier beverages
Number of subjects: 154
Study 26825280 — intervention group
Group type: EXPERIMENTAL
Intervention: Autorefraction preoperatively
Number of subjects: 27
Study 26825280 — intervention group
Group type: EXPERIMENTAL
Intervention: Autorefraction postoperatively
Number of subjects: 27
Study 26825280 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective refraction preoperatively
Number of subjects: 27
Study 26251920 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g fish oil/day (540 mg EPA + 360 mg DHA)
Number of subjects: 83
Study 26251920 — intervention group
Group type: COMPARATOR
Intervention: 3 g soy oil/day (placebo)
Number of subjects: 83
Study 23433768 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg/day
Number of subjects: 164
Study 23433768 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg/day
Number of subjects: 164
Study 21153806 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 18
Study 21153806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 19659504 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil 20 mg + Amlodipine 5 mg
Number of subjects: 18
Study 19659504 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan medoxomil 20 mg alone
Number of subjects: 18
Study 19659504 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil 20 mg + Atenolol 50 mg
Number of subjects: 18
Study 17496229 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2)
Number of subjects: 238
Study 17496229 — intervention group
Group type: COMPARATOR
Intervention: Not receiving HBO2
Number of subjects: 238
Study 15150666 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-flexion radiography with a specially designed frame (SynaFlexer)
Number of subjects: 165
Study 15150666 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated analysis of JSW measurements
Number of subjects: 165
Study 15150666 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat knee radiographs using automated analysis
Number of subjects: 165
Study 11314888 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating rotating electric toothbrush (slower head speed)
Number of subjects: 16
Study 11314888 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating rotating electric toothbrush (faster head speed)
Number of subjects: 16
Study 11314888 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 16
Study 11314888 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste slurry (3 g/10 ml water)
Number of subjects: 16
Study 9072571 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (2,000 rad) followed by cystectomy
Number of subjects: 140
Study 9072571 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 140
Study 8202902 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (sustained release preparation, orally, adjusted to achieve blood level above 55.5 mumol/l)
Number of subjects: 22
Study 8202902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6611576 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency transcutaneous electrical nerve stimulation (TNS)
Number of subjects: 33
Study 6611576 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-like transcutaneous electrical nerve stimulation (TNS)
Number of subjects: 33
Study 6611576 — intervention group
Group type: COMPARATOR
Intervention: Placebo TNS
Number of subjects: 33
Study 6611576 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength measurements
Number of subjects: 33
Study 31464354 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing speed for water (measured at 90 mL)
Number of subjects: 115
Study 31464354 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing speed <10 mL/s
Number of subjects: 115
Study 31464354 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized cutoff value for detection of aspiration
Number of subjects: 115
Study 29161684 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity CRRT (effluent flow 40 mL/kg/h)
Number of subjects: 444
Study 29161684 — intervention group
Group type: COMPARATOR
Intervention: Lower intensity CRRT (effluent flow 25 mL/kg/h)
Number of subjects: 444
Study 29161684 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity CRRT
Number of subjects: 444
Study 27887653 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular cooling
Number of subjects: 934
Study 27887653 — intervention group
Group type: COMPARATOR
Intervention: Surface cooling
Number of subjects: 934
Study 24267270 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreaded shoes
Number of subjects: 18
Study 24267270 — intervention group
Group type: COMPARATOR
Intervention: Treaded shoes
Number of subjects: 18
Study 24267270 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe/floor design
Number of subjects: 18
Study 22512470 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottom‐up training including activities focused on auditory perception, discrimination, and phonological awareness
Number of subjects: 55
Study 22512470 — intervention group
Group type: EXPERIMENTAL
Intervention: Top‐down training including a range of language activities
Number of subjects: 55
Study 22512470 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal FM systems
Number of subjects: 55
Study 22512470 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study 20796146 — intervention group
Group type: EXPERIMENTAL
Intervention: PegIFN alfa‐2b
Number of subjects: 58
Study 20796146 — intervention group
Group type: COMPARATOR
Intervention: Conventional IFN alfa‐2b
Number of subjects: 58
Study 20796146 — intervention group
Group type: COMPARATOR
Intervention: Non-HBeAg seroconversion
Number of subjects: 58
Study 17696230 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-03/ES (two capsules twice daily for six months)
Number of subjects: 25
Study 17239273 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral estrogen
Number of subjects: 0
Study 17239273 — intervention group
Group type: COMPARATOR
Intervention: Conventional androgen deprivation therapy (ADT)
Number of subjects: 0
Study 15133780 — intervention group
Group type: EXPERIMENTAL
Intervention: New therapy during open-label follow-up phase
Number of subjects: 0
Study 15133780 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 11026856 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-hold cine MRI with stereological analysis
Number of subjects: 11
Study 8872767 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consecutive administration of 9 million units (MU) IFN‐alpha for 2 weeks and thereafter 3 MU intermittently 3 times weekly for 22 weeks (Group A)
Number of subjects: 81
Study 8872767 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusively intermittent administration; 9 MU IFN‐alpha twice weekly or 6 MU IFN‐alpha thrice weekly for 24 weeks (Group B)
Number of subjects: 81
Study 8872767 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 81
Study 1510045 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal brackets
Number of subjects: 75
Study 1510045 — intervention group
Group type: EXPERIMENTAL
Intervention: Silkon brackets
Number of subjects: 75
Study 1510045 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcend 2000 brackets
Number of subjects: 75
Study 1510045 — intervention group
Group type: EXPERIMENTAL
Intervention: Debonded Transcend 2000 brackets
Number of subjects: 75
Study 1510045 — intervention group
Group type: EXPERIMENTAL
Intervention: Debonded silanized Transcend 2000 brackets
Number of subjects: 75
Study 6239689 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone at a dose of 5 mg twice a day
Number of subjects: 33
Study 6239689 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen at a dose of 10 mg twice a day
Number of subjects: 33
Study 6239689 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen with additional prednisolone
Number of subjects: 33
Study 6239689 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prednisolone)
Number of subjects: 33
Study 6239689 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment response
Number of subjects: 33
Study 29983128 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Mindfulness Program for Voices (iMPV)
Number of subjects: 14
Study 27095187 — intervention group
Group type: EXPERIMENTAL
Intervention: Learned Helplessness (LH) measured by the Rheumatology Attitude Index (RAI)
Number of subjects: 115
Study 27095187 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Efficacy (SE) measured by the Arthritis Self-efficacy Scale (ASES)
Number of subjects: 115
Study 27095187 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Activity measured by the Clinical Disease Activity Index (CDAI)
Number of subjects: 115
Study 25920500 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide MMX 9 mg as monotherapy
Number of subjects: 0
Study 25920500 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide MMX 9 mg as add-on therapy to 5-ASAs
Number of subjects: 0
Study 25920500 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide MMX 9 mg monotherapy in CORE I study extension
Number of subjects: 0
Study 25920500 — intervention group
Group type: COMPARATOR
Intervention: Budesonide MMX 9 mg
Number of subjects: 0
Study 23973954 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonapical RV lead location (n=86)
Number of subjects: 742
Study 23973954 — intervention group
Group type: COMPARATOR
Intervention: Apical RV lead location (n=656)
Number of subjects: 742
Study 23973954 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonapical RV lead location
Number of subjects: 742
Study 23973954 — intervention group
Group type: COMPARATOR
Intervention: Apical RV lead location
Number of subjects: 742
Study 21356040 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg)
Number of subjects: 8
Study 21356040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 19515739 — intervention group
Group type: EXPERIMENTAL
Intervention: Active diet intervention (increase in n-3 intake and decrease in n-6 intake)
Number of subjects: 616
Study 19515739 — intervention group
Group type: COMPARATOR
Intervention: Control diet intervention
Number of subjects: 616
Study 16752263 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 microg vaginal tablets of misoprostol
Number of subjects: 120
Study 16752263 — intervention group
Group type: COMPARATOR
Intervention: One-eighth of a 200-microg oral tablet administered intravaginally
Number of subjects: 120
Study 15701186 — intervention group
Group type: EXPERIMENTAL
Intervention: Three monthly subcutaneous injections of 3.6 mg of goserelin
Number of subjects: 45
Study 15701186 — intervention group
Group type: COMPARATOR
Intervention: Single subcutaneous injection of 10.8 mg of goserelin
Number of subjects: 45
Study 15701186 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 45
Study 11417282 — intervention group
Group type: EXPERIMENTAL
Intervention: Double gloves with indicator
Number of subjects: 200
Study 11417282 — intervention group
Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 200
Study 11417282 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 200
Study 9267920 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited microbiological investigation
Number of subjects: 40
Study 9267920 — intervention group
Group type: COMPARATOR
Intervention: Full microbiological investigation
Number of subjects: 40
Study 3527029 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 0
Study 3527029 — intervention group
Group type: COMPARATOR
Intervention: Meglumine iothalamate
Number of subjects: 0
Study 30306229 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg E2-valerate
Number of subjects: 34
Study 30306229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 27496252 — intervention group
Group type: COMPARATOR
Intervention: Conventional implants (control group, Ø3.3‐3.7mm, L11‐13mm)
Number of subjects: 26
Study 27496252 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini implants (study group, Ø1.8‐2.4mm, L13‐15mm)
Number of subjects: 26
Study 25287156 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteinuria present (P/C ratio >23 mg/mmol)
Number of subjects: 64
Study 25287156 — intervention group
Group type: COMPARATOR
Intervention: No proteinuria (P/C ratio ≤23 mg/mmol)
Number of subjects: 64
Study 25287156 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteinuria
Number of subjects: 64
Study 25287156 — intervention group
Group type: EXPERIMENTAL
Intervention: P/C ratio
Number of subjects: 64
Study 22929636 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 75
Study 22929636 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 150 mcg
Number of subjects: 75
Study 22929636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 20063135 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1.32 microg.kg(‐1) co-administered with propofol 2.5 mg.kg(‐1)
Number of subjects: 68
Study 20063135 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil doses of 0.25, 0.5, 1, or 2 microg.kg(‐1)
Number of subjects: 68
Study 17900324 — intervention group
Group type: EXPERIMENTAL
Intervention: Basket group (N = 30)
Number of subjects: 56
Study 17900324 — intervention group
Group type: COMPARATOR
Intervention: Brush group (N = 26)
Number of subjects: 56
Study 17900324 — intervention group
Group type: EXPERIMENTAL
Intervention: Basket group (N = 30) with presampling balloon dilation
Number of subjects: 56
Study 17900324 — intervention group
Group type: COMPARATOR
Intervention: Brush group (N = 26) with presampling balloon dilation
Number of subjects: 56
Study 17900324 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 56
Study 15986946 — intervention group
Group type: EXPERIMENTAL
Intervention: Beautifil (for cervical restorations)
Number of subjects: 15
Study 15986946 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactmer (for cervical restorations)
Number of subjects: 15
Study 15986946 — intervention group
Group type: EXPERIMENTAL
Intervention: Beautifil (for occlusal restorations)
Number of subjects: 15
Study 15515566 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettement-adhesive group (42 cases)
Number of subjects: 83
Study 15515566 — intervention group
Group type: COMPARATOR
Intervention: Control group (41 cases) - treated with Vaseline gauze packing
Number of subjects: 83
Study 9430541 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% dorzolamide drops
Number of subjects: 19
Study 9430541 — intervention group
Group type: COMPARATOR
Intervention: Placebo drops
Number of subjects: 19
Study 8624292 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed treatment (FT) - 4 full MOPP/ABVD courses
Number of subjects: 88
Study 8624292 — intervention group
Group type: COMPARATOR
Intervention: Individual treatment (IT) - treatment up to complete remission (CR)
Number of subjects: 88
Study 2768664 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic analgesia
Number of subjects: 0
Study 2768664 — intervention group
Group type: COMPARATOR
Intervention: Placebo analgesia
Number of subjects: 0
Study 2768664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonhypnotic suggestion for analgesia
Number of subjects: 0
Study 2768664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive coping
Number of subjects: 0
Study 781226 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen calcium (FC)
Number of subjects: 20
Study 781226 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (ASA)
Number of subjects: 20
Study 781226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30770766 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter removal on postoperative day 2
Number of subjects: 220
Study 30770766 — intervention group
Group type: COMPARATOR
Intervention: Catheter removal on postoperative day 7
Number of subjects: 220
Study 28549620 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid prescribing guidelines implemented in April 2012
Number of subjects: 0
Study 25301892 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative template obtained for review at the time of ORIF (group 1)
Number of subjects: 0
Study 25301892 — intervention group
Group type: COMPARATOR
Intervention: Contralateral radiograph obtained after surgery (group 2)
Number of subjects: 0
Study 22868657 — intervention group
Group type: EXPERIMENTAL
Intervention: raloxifene hydrochloride 60 mg/day
Number of subjects: 144
Study 22868657 — intervention group
Group type: COMPARATOR
Intervention: alfacalcidol 1 μg/day
Number of subjects: 144
Study 22868657 — intervention group
Group type: COMPARATOR
Intervention: no medication
Number of subjects: 144
Study 21575502 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine group (large dose compound Sophora flavescens Ait injection, 20 ml/d, 21 days as a cycle)
Number of subjects: 96
Study 21575502 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy group
Number of subjects: 96
Study 21575502 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine group
Number of subjects: 96
Study 19565554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Tool Kit (n = 458)
Number of subjects: 921
Study 19565554 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 463)
Number of subjects: 921
Study 16784623 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive THA with anterior incision (Group 1)
Number of subjects: 120